TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 156 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $53,479,000 | +144.2% | 710,681 | -12.9% | 0.01% | +150.0% |
| Q1 2022 | $21,903,000 | -67.2% | 815,755 | -41.7% | 0.00% | -60.0% |
| Q4 2021 | $66,714,000 | -53.5% | 1,398,603 | -35.2% | 0.01% | -54.5% |
| Q3 2021 | $143,466,000 | -40.1% | 2,159,654 | -29.6% | 0.01% | -42.1% |
| Q2 2021 | $239,471,000 | -60.4% | 3,069,360 | -52.0% | 0.02% | -63.5% |
| Q1 2021 | $604,352,000 | -20.2% | 6,389,174 | +2.8% | 0.05% | -22.4% |
| Q4 2020 | $757,342,000 | +37.1% | 6,215,363 | -1.7% | 0.07% | +19.6% |
| Q3 2020 | $552,581,000 | +68.4% | 6,325,320 | +24.5% | 0.06% | +55.6% |
| Q2 2020 | $328,066,000 | +70.9% | 5,079,197 | +18.2% | 0.04% | +33.3% |
| Q1 2020 | $191,977,000 | -36.3% | 4,298,638 | -11.2% | 0.03% | -18.2% |
| Q4 2019 | $301,523,000 | +123.6% | 4,840,647 | +35.0% | 0.03% | +106.2% |
| Q3 2019 | $134,870,000 | +11.7% | 3,586,955 | +21.0% | 0.02% | +14.3% |
| Q2 2019 | $120,695,000 | – | 2,965,494 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |